The The Balanced Mind Foundation (formerly the Children and Adolescent Bipolar Foundation) has resources for families and youths living with bipolar disorder. A section of the site is targeted at educators teaching children with bipolar, and another at teens with the disorder.
The Brain & Behavior Research Foundation’s site answers frequently asked questions about mental illnesses, including bipolar disorder, and discusses research advances in treating and understanding these illnesses.
Depression and Bipolar Support Alliance's easy-to-use Web site offers helpful information about mood disorders, support groups, the Association's programs and publications. The site also provides links and resources for further information.
The Juvenile Bipolar Research Foundation provides an introduction to bipolar disorder in children, with an overview, frequently asked questions, and suggested resources.
This easy-to-use service of the National Library of Medicine provides links to articles, pamphlets, and organizations relating to bipolar disorder.
Mental Health America provides information about many forms of mental illness, treatment options, medication resources, and ways to get help.
The National Alliance on Mental Illness Web site houses resources on a host of mental illnesses, such as depression, obsessive-compulsive disorder, and borderline personality disorder. The site also provides information on treatments, support groups, and recovery from mental illness.
Scientists are finding evidence that neuroinflammation can alter mood and cognition, perhaps enough to help cause psychiatric disorders.
Is there a link between a father’s age and his child’s vulnerability to
psychiatric problems? Two recent studies suggest that children born to
middle-aged men are more likely than their older siblings to develop a range of
mental difficulties, including bipolar disorder, autism, and schizophrenia.
When it comes to funding drug research to treat depression, schizophrenia, anxiety, and other psychiatric disorders, the global pharmaceutical industry prefers to invest its research dollars in cancer, metabolism, autoimmunity, and other disease areas. This comes despite the fact that one in five Americans currently take at least one psychiatric drug and that mental disorders are recognized worldwide. The author traces the evolution of psychiatric drug development, the reasons for its retreat, and what needs to change to meet the growing demand.